diethylstilbestrol DES historical
Selected indexed studies
- Diethylstilbestrol (DES) update: recommendations for the identification and management of DES-exposed individuals. (J Midwifery Womens Health, 2003) [PMID:12589302]
- Pregnant women, prescription, and fetal risk. (Handb Clin Neurol, 2020) [PMID:32958185]
- The history of DES, lessons to be learned. (Pharm World Sci, 2005) [PMID:16096877]
_Worker-drafted node — pending editorial review._
Connections
No connections recorded yet.
Sources
- Diethylstilbestrol (DES) update: recommendations for the identification and management of DES-exposed individuals. (2003) pubmed
- Pregnant women, prescription, and fetal risk. (2020) pubmed
- The history of DES, lessons to be learned. (2005) pubmed
- Breast cancer in mothers prescribed diethylstilbestrol in pregnancy. Further follow-up. (1993) pubmed
- Lessons learned from perinatal exposure to diethylstilbestrol. (2004) pubmed
- Do endocrine disruptors cause hypospadias? (2014) pubmed
- Long-term cancer risk in women given diethylstilbestrol (DES) during pregnancy. (2001) pubmed
- Clear Cell Carcinoma of the Cervix. (2026) pubmed
- Clear Cell Adenocarcinoma of the Uterine Cervix and Vagina in Children Without Exposure to Diethylstilbestrol. (2025) pubmed
- Postnatal exposure to various benzophenones at environmentally relevant levels enhances the susceptibility of mammalian testes to cyclophosphamide-induced spermatogenic stress in adulthood. (2025) pubmed